Article
The future of primary intraocular lymphoma (retinal lymphoma).
Ocular immunology and inflammation - 1 Jan 2000
Chan Chi-Chao, Fisson Sylvain, Bodaghi Bahram
Abstract excerpt
Basic science and clinical investigations in cancer research have contributed to our understanding of the genetic causes of various neoplasms and discovery of novel therapeutic interventions to fight malignancies such as lymphoma. During this exciting time, we have witnessed the advent of new technologies to further characterize primary intraocular lymphoma (PIOL), or retinal lymphoma, which is selected as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
